Business Description
Proteomics International Laboratories Ltd
ISIN : AU000000PIQ0
Description
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.01 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 27.6 | |||||
| Beneish M-Score | -4.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -18.6 | |||||
| 3-Year EBITDA Growth Rate | -40.8 | |||||
| 3-Year EPS without NRI Growth Rate | -22.1 | |||||
| 3-Year FCF Growth Rate | -26 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 41.72 | |||||
| Future 3-5Y Total Revenue Growth Rate | 119.64 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.03 | |||||
| 9-Day RSI | 53.67 | |||||
| 14-Day RSI | 49.7 | |||||
| 6-1 Month Momentum % | -23.98 | |||||
| 12-1 Month Momentum % | -15.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.13 | |||||
| Quick Ratio | 10.13 | |||||
| Cash Ratio | 7.34 | |||||
| Days Sales Outstanding | 64.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | -0.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1022.98 | |||||
| Net Margin % | -714.91 | |||||
| FCF Margin % | -672.2 | |||||
| ROE % | -82.66 | |||||
| ROA % | -68.58 | |||||
| ROIC % | -292.37 | |||||
| ROC (Joel Greenblatt) % | -340.87 | |||||
| ROCE % | -110.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 101.52 | |||||
| PB Ratio | 9.87 | |||||
| Price-to-Tangible-Book | 10 | |||||
| EV-to-EBIT | -9.01 | |||||
| EV-to-EBITDA | -9.77 | |||||
| EV-to-Revenue | 92.04 | |||||
| EV-to-FCF | -13.58 | |||||
| Price-to-Net-Current-Asset-Value | 11.67 | |||||
| Price-to-Net-Cash | 17.5 | |||||
| Earnings Yield (Greenblatt) % | -11.11 | |||||
| FCF Yield % | -6.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Proteomics International Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.892 | ||
| EPS (TTM) (A$) | -0.051 | ||
| Beta | 0.05 | ||
| Volatility % | 31.57 | ||
| 14-Day RSI | 49.7 | ||
| 14-Day ATR (A$) | 0.025129 | ||
| 20-Day SMA (A$) | 0.69425 | ||
| 12-1 Month Momentum % | -15.34 | ||
| 52-Week Range (A$) | 0.55 - 1.4 | ||
| Shares Outstanding (Mil) | 131 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Proteomics International Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Proteomics International Laboratories Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Proteomics International Laboratories Ltd Frequently Asked Questions
What is Proteomics International Laboratories Ltd(ASX:PIQ)'s stock price today?
The current price of ASX:PIQ is A$0.70. The 52 week high of ASX:PIQ is A$1.40 and 52 week low is A$0.55.
When is next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ)?
The next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ) is .
Does Proteomics International Laboratories Ltd(ASX:PIQ) pay dividends? If so, how much?
Proteomics International Laboratories Ltd(ASX:PIQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers